Domů › Mnohočetný myelom › New Jersey › Edison
Klinické studie Mnohočetný myelom v Edison, NJ
22 studií pro Mnohočetný myelom hledá účastníky v lokalitách v Edison a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
Probíhá náborFáze 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · Vzdálenost 15 mi
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Probíhá náborFáze 3
- Astera Cancer Care, East Brunswick · Vzdálenost 6 mi
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Probíhá náborFáze 3
- Astera Cancer Care, East Brunswick · Vzdálenost 6 mi
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Probíhá náborFáze 3
- MSK Basking Ridge, Basking Ridge · Vzdálenost 15 mi
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Probíhá náborFáze 4
- Rutgers Cancer Institute of New Jersey, New Brunswick · Vzdálenost 3 mi
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
Probíhá náborFáze 2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · Vzdálenost 15 mi
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Probíhá náborFáze 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · Vzdálenost 3 mi
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Probíhá náborFáze 3
- MSK Basking Ridge, Basking Ridge · Vzdálenost 15 mi
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
Probíhá náborFáze 1
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · Vzdálenost 15 mi
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Probíhá náborFáze 3
- Research Site, East Brunswick · Vzdálenost 6 mi
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
Probíhá náborObservační studie
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · Vzdálenost 15 mi
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
Probíhá náborFáze 1/2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · Vzdálenost 15 mi
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
Probíhá náborFáze 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · Vzdálenost 15 mi
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
Probíhá náborFáze 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · Vzdálenost 15 mi
Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization
Probíhá náborRaná fáze 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · Vzdálenost 3 mi
- RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick, New Brunswick · Vzdálenost 3 mi
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
Probíhá náborFáze 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · Vzdálenost 3 mi
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
Probíhá náborFáze 1
- Rutgers Cancer Institute of New Jersey /ID# 266833, New Brunswick · Vzdálenost 3 mi
A Dietary Study for People With Multiple Myeloma
Probíhá nábor
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · Vzdálenost 15 mi
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Probíhá náborFáze 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · Vzdálenost 3 mi
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
Probíhá náborFáze 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · Vzdálenost 15 mi
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · Vzdálenost 15 mi
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Probíhá nábor
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · Vzdálenost 15 mi
Studie Mnohočetný myelom v jiných městech
- New York City, NY60 studií
- Boston, MA42 studií
- Atlanta, GA41 studií
- Houston, TX38 studií
- Durham, NC37 studií
- Nashville, TN32 studií
- Denver, CO27 studií
- Rochester, MN24 studií
- St. Louis, MO24 studií
- Columbus, OH24 studií
- Baldwin Park, CA23 studií
- Chicago, IL22 studií
Další studie v Edison
- Rakovina prsu68 studií
- Nemalobuněčný plicní karcinom47 studií
- Rakovina (všechny typy)33 studií
- Rakovina prostaty29 studií
- Kolorektální karcinom23 studií
- Rakovina plic23 studií
- Rakovina močového měchýře21 studií
- Metastatický karcinom20 studií
- Rakovina vaječníků20 studií
- Akutní myeloidní leukemie20 studií
- Rakovina endometria19 studií
- Uroteliální (přechodnobuněčný) karcinom18 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.